tiprankstipranks
Bio-Rad sees FY25 currency neutral revenue growth 1.5%-3.5%
PremiumThe FlyBio-Rad sees FY25 currency neutral revenue growth 1.5%-3.5%
8d ago
Bio-Rad to acquire Stilla Technologies
Premium
The Fly
Bio-Rad to acquire Stilla Technologies
8d ago
Bio-Rad price target lowered to $345 from $360 at Wells Fargo
Premium
The Fly
Bio-Rad price target lowered to $345 from $360 at Wells Fargo
9d ago
Bio-Rad Laboratories Reports Q3 2024 Earnings Growth
PremiumCompany AnnouncementsBio-Rad Laboratories Reports Q3 2024 Earnings Growth
4M ago
Bio-Rad  reports Q3 EPS $2.01, consensus $1.16
Premium
The Fly
Bio-Rad reports Q3 EPS $2.01, consensus $1.16
4M ago
Bio-Rad sees non-GAAP revenue down 2.5%-4% for FY24
Premium
The Fly
Bio-Rad sees non-GAAP revenue down 2.5%-4% for FY24
4M ago
Palantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23
PremiumThe FlyPalantir, Dell Technologies, Erie Indemnity to be added to S&P 500 on 9/23
6M ago
Wells Fargo initiates Bio-Rad with an Equal Weight, $340 price target
Premium
The Fly
Wells Fargo initiates Bio-Rad with an Equal Weight, $340 price target
6M ago
Bio-Rad initiated with an Equal Weight at Wells Fargo
Premium
The Fly
Bio-Rad initiated with an Equal Weight at Wells Fargo
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100